8-K
filed December 29, 2023, 6:59 PM ET
ticker OPCH
CIK 0001014739
leadership
confidence high
sentiment neutral
materiality 0.40
Option Care Health appoints two new directors; Sahney resigns; Denness separation finalized
Option Care Health, Inc.
- Barbara Bodem (former DENTSPLY SIRONA CFO) and Norman Wright (ex-UHG exec) join board effective Jan 2, 2024; Bodem on Audit & Nominating, Wright on Compensation & Nominating.
- Nitin Sahney resigns from board effective Jan 1, 2024; no disagreement cited.
- Former CCO Richard Denness to serve as special advisor through Mar 31, 2024; receives base salary, target bonus ($358,440), and continued equity vesting during transition.
- Post-separation: 9 months base salary severance and COBRA reimbursement; subject to non-compete (12 months) and non-solicit (18 months) covenants.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Nitin Sahney resigned as Director at Option Care Health, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Nitin Sahney, a member of the Board, notified the Company of his resignation from the Board, effective as of the close of business on January 1, 2024
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Norman Wright was appointed as Director at Option Care Health, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
appointed Barbara Bodem and Norman Wright to the Board effective January 2, 2024.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Barbara Bodem was appointed as Director at Option Care Health, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
appointed Barbara Bodem and Norman Wright to the Board effective January 2, 2024.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Richard Denness departed as Chief Commercial Officer at Option Care Health, Inc..
- Action
- ceased to serve
- Role
- Chief Commercial Officer
Exact text from the filing
Richard Denness had ceased to serve as the Company’s Chief Commercial Officer, effective December 7, 2023
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.